ストックスクリーナーアプリを入手
14.31
1.38%
-0.20
プレマーケット:
14.35
0.04
+0.28%
前日終値:
$14.51
開ける：
$14.58
24時間の取引高:
633.47K
Relative Volume:
0.55
時価総額：
$1.89B
収益：
$260.11M
当期純損益:
$60.64M
株価収益率:
33.28
EPS:
0.43
ネットキャッシュフロー:
$92.29M
1週間 パフォーマンス:
+0.35%
1か月 パフォーマンス:
-6.35%
6か月 パフォーマンス:
+26.41%
1年 パフォーマンス:
+83.23%
1日の値動き範囲:
$14.23
$14.66
1週間の範囲:
$14.20
$14.69
52週間の値動き範囲:
$6.55
$16.54
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
名前
Aurinia Pharmaceuticals Inc
セクター
電話
250-744-2487
住所
#140, 14315 - 118 AVENUE, EDMONTON, BC
Compare AUPH vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AUPH
Aurinia Pharmaceuticals Inc
|
14.31 | 1.91B | 260.11M | 60.64M | 92.29M | 0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-03 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-11-07 | アップグレード | Jefferies | Hold → Buy |
| 2025-11-05 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-07-30 | 再開されました | H.C. Wainwright | Buy |
| 2022-11-04 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-05-05 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-12-10 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-10-28 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2021-01-25 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-11-03 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-17 | 開始されました | BTIG Research | Buy |
| 2020-05-05 | 開始されました | Cowen | Outperform |
| 2020-01-10 | 開始されました | Jefferies | Buy |
| 2019-12-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-03-16 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2018-02-08 | 開始されました | RBC Capital Mkts | Outperform |
| 2017-10-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-05-18 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-04-11 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-03-22 | 繰り返されました | FBR & Co. | Outperform |
| 2016-12-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-08-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-06-30 | 開始されました | H.C. Wainwright | Buy |
| 2015-05-08 | 開始されました | MLV & Co | Buy |
すべてを表示
Aurinia Pharmaceuticals Inc (AUPH) 最新ニュース
83,780 Shares in Aurinia Pharmaceuticals Inc $AUPH Purchased by Navellier & Associates Inc. - MarketBeat
Is Aurinia Pharmaceuticals Inc. stock a smart retirement pickEarnings Performance Report & Free Technical Confirmation Trade Alerts - mfd.ru
Aurinia Pharmaceuticals Inc (AUPH): Investor Outlook and Analyst Consensus Reveal Promising 14.71% Upside - DirectorsTalk Interviews
Investing in Aurinia Pharmaceuticals (NASDAQ:AUPH) a year ago would have delivered you a 80% gain - Yahoo Finance
Precision Trading with Aurinia Pharmaceuticals Inc (AUPH) Risk Zones - Stock Traders Daily
Aug Swings: Is Aurinia Pharmaceuticals Incs growth already priced inQuarterly Investment Review & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Hussman Strategic Advisors Inc. Cuts Position in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Technical Reactions to AUPH Trends in Macro Strategies - Stock Traders Daily
Bull Run: Is IAC Inc a good ESG investment2025 Price Targets & Scalable Portfolio Growth Methods - baoquankhu1.vn
Does Aurinia Pharmaceuticals Inc. offer margin of safetyJuly 2025 Big Picture & Safe Capital Investment Plans - mfd.ru
Signal Recap: Why is Aurinia Pharmaceuticals Inc stock going upJuly 2025 Opening Moves & Risk Managed Investment Strategies - baoquankhu1.vn
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Ritholtz Wealth Management Buys Shares of 84,515 Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Best Canadian Stocks to Buy With $7,000 Right Now - Yahoo! Finance Canada
Aug Rallies: Will Aurinia Pharmaceuticals Inc benefit from government policyQuarterly Earnings Report & Daily Growth Stock Investment Tips - baoquankhu1.vn
Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options - sharewise.com
Aurinia downgraded at RBC on risk-reward setup - MSN
How Investors May Respond To Aurinia Pharmaceuticals (AUPH) Expanding Autoimmune Pipeline And Deepening Otsuka Collaboration - Sahm
Trading the Move, Not the Narrative: (AUPH) Edition - Stock Traders Daily
Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: 9.08% Potential Upside Amid Promising Biotech Innovations - DirectorsTalk Interviews
With 54% institutional ownership, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a favorite amongst the big guns - Yahoo Finance
How Aurinia Pharmaceuticals Inc. stock responds to policy changesWeekly Earnings Recap & Growth Focused Entry Point Reports - ulpravda.ru
Aurinia Pharmaceuticals (NASDAQ:AUPH) Share Price Passes Above 50-Day Moving AverageHere's Why - MarketBeat
How strong is Aurinia Pharmaceuticals Inc. stock balance sheetJuly 2025 Patterns & Growth Oriented Trade Recommendations - ulpravda.ru
Is Aurinia Pharmaceuticals Inc. stock a top pick in earnings seasonTrade Analysis Report & Precise Swing Trade Entry Alerts - ulpravda.ru
Earnings Report: Why Aurinia Pharmaceuticals Inc. (IKAP) stock stays resilientProfit Target & Weekly Top Gainers Trade List - Улправда
Is Aurinia Pharmaceuticals Inc. (IKAP) stock resilient in recession scenarios2025 Technical Patterns & Low Risk High Reward Ideas - Улправда
Why Aurinia Pharmaceuticals Inc. (IKAP) stock is listed among top recommendationsPortfolio Update Summary & Stock Timing and Entry Methods - Улправда
Why retail investors favor Aurinia Pharmaceuticals Inc. stockSupport Zone Identification & Free High Yield Growth Strategies - Улправда
Aruinia discloses FDA information request on Lupkynis amid top regulator’s exit - MSN
Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Riding the Biotech Wave with 8.93% Potential Upside - DirectorsTalk Interviews
RBC Capital Downgrades Aurinia Pharmaceuticals (AUPH) - MSN
Aug Sectors: Why retail investors favor Aurinia Pharmaceuticals Inc. stockTrade Entry Report & Smart Swing Trading Alerts - moha.gov.vn
Aurinia Pharmaceuticals IncCommon Shares (NQ: AUPH - FinancialContent
(AUPH) Volatility Zones as Tactical Triggers - Stock Traders Daily
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Down 3.6%Here's Why - MarketBeat
Aurinia Pharmaceuticals (AUPH) Price Target Increased by 34.15% to 16.03 - MSN
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Is a Favorite Amongst Institutional Investors Who Own 54% - 富途牛牛
Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: A Biotech Contender with a 4.89% Upside - DirectorsTalk Interviews
Spoke.comAurinia Pharmaceuticals IncCommon Shares (Nasdaq:AUPH) Stock Quote - FinancialContent
Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? - AOL.com
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Is Aurinia Pharmaceuticals (AUPH) Outperforming Other Medical Stocks This Year? - sharewise.com
Aurinia Pharmaceuticals (NASDAQ:AUPH) rises 3.1% this week, taking three-year gains to 292% - simplywall.st
Understanding the Setup: (AUPH) and Scalable Risk - Stock Traders Daily
How Aurinia Pharmaceuticals Inc. (IKAP) stock trades pre earningsDebt-to-Equity Ratio Analysis & Watch and Learn From Live Trades - bollywoodhelpline.com
Aurinia Pharmaceuticals Inc (AUPH): Navigating Biotech with a Strong 20.65% ROE and Promising Analyst Ratings - DirectorsTalk Interviews
Aurinia Pharmaceuticals stock hits 52-week high at 16.49 USD By Investing.com - Investing.com Nigeria
Aurinia Pharmaceuticals (NASDAQ:AUPH) Hits New 12-Month HighHere's Why - MarketBeat
Aurinia Pharmaceuticals stock hits 52-week high at 16.49 USD - Investing.com
Why Aurinia Pharmaceuticals Inc. (IKAP) stock gets analyst attentionWeekly Market Outlook & Stock Timing and Entry Methods - Улправда
Aurinia Pharmaceuticals Inc (AUPH) 財務データ
収益
当期純利益
現金流量
EPS
1.24%
0.19%
大文字化:
|
ボリューム (24 時間):